| Patent | Date |
|---|
Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
Grant 8,058,264 - Firnges , et al. November 15, 2 | 2011-11-15 |
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
Grant 7,772,225 - Antel , et al. August 10, 2 | 2010-08-10 |
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
Grant 7,767,692 - Jasserand , et al. August 3, 2 | 2010-08-03 |
Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
Grant 7,763,607 - Antel , et al. July 27, 2 | 2010-07-27 |
NK1 and NK2-antagonists and compositions and methods of using the same
Grant 7,592,344 - Antel , et al. September 22, 2 | 2009-09-22 |
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof
Grant 7,547,708 - Antel , et al. June 16, 2 | 2009-06-16 |
Sulfamate Compounds and Uses Thereof
App 20090104126 - SCHOEN; Uwe ; et al. | 2009-04-23 |
Use of CBx cannabinoid receptor modulators as potassium channel modulators
App 20070254863 - Antel; Jochen ; et al. | 2007-11-01 |
Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
App 20070254862 - Antel; Jochen ; et al. | 2007-11-01 |
Method of preparing pharmaceutical compositions
Grant 7,282,325 - Hebebrand , et al. October 16, 2 | 2007-10-16 |
Methods Of Using Potassium Channel Inhibiting Compounds
App 20070191357 - Antel; Jochen ; et al. | 2007-08-16 |
Non-peptidic BRS-3 agonists
Grant 7,244,743 - Weber , et al. July 17, 2 | 2007-07-17 |
Method of treating or inhibiting obesity
Grant 7,238,470 - Hebebrand , et al. July 3, 2 | 2007-07-03 |
NK1 and NK2-antagonists and compositions and methods of using the same
App 20070149537 - Antel; Jochen ; et al. | 2007-06-28 |
N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
App 20070149512 - Antel; Jochen ; et al. | 2007-06-28 |
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof
App 20070117823 - Antel; Jochen ; et al. | 2007-05-24 |
Alkyl carbamate-substituted .beta.-lactones, process for their preparation, and pharmaceutical compositions containing them
Grant 7,074,822 - Antel , et al. July 11, 2 | 2006-07-11 |
Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
App 20060128673 - Firnges; Michael ; et al. | 2006-06-15 |
Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
App 20050261292 - Antel, Jochen ; et al. | 2005-11-24 |
Novel Medical Uses Of 4,5-dihydro-1h-pyrazole Derivatives Having Cb1- Antagonistic Activity
App 20050239859 - Antel, Jochen ; et al. | 2005-10-27 |
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
Grant 6,946,243 - Hebebrand , et al. September 20, 2 | 2005-09-20 |
Alkyl carbamate-substituted beta-lactones, process and intermediate products for their preparation, and pharmaceutical compositions containing them
App 20050197386 - Antel, Jochen ; et al. | 2005-09-08 |
Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatment
Grant 6,930,207 - Antel , et al. August 16, 2 | 2005-08-16 |
Non-peptidic BRS-3 agonists
App 20050171146 - Weber, Dirk ; et al. | 2005-08-04 |
Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
App 20050143441 - Antel, Jochen ; et al. | 2005-06-30 |
Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds
App 20050124660 - Antel, Jochen ; et al. | 2005-06-09 |
Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
Grant 6,900,322 - Reggelin , et al. May 31, 2 | 2005-05-31 |
Use of selective CB1-antagonists in medical treatments
App 20050101585 - Antel, Jochen ; et al. | 2005-05-12 |
Novel medical uses of 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
App 20050080125 - Antel, Jochen ; et al. | 2005-04-14 |
Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatment
App 20040214901 - Antel, Jochen ; et al. | 2004-10-28 |
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20040167214 - Hebebrand, Johannes ; et al. | 2004-08-26 |
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20040167213 - Hebebrand, Johannes ; et al. | 2004-08-26 |
1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
App 20040152732 - Jasserand, Daniel ; et al. | 2004-08-05 |
1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
Grant 6,770,649 - Jasserand , et al. August 3, 2 | 2004-08-03 |
1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
App 20030125557 - Jasserand, Daniel ; et al. | 2003-07-03 |
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
App 20020022245 - Hebebrand, Johannes ; et al. | 2002-02-21 |
Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
Grant 5,677,297 - Waldeck , et al. October 14, 1 | 1997-10-14 |
| 